DIAMOND BIOFUND INC - Asset Resilience Ratio
DIAMOND BIOFUND INC (6901) has an Asset Resilience Ratio of 15.65% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does DIAMOND BIOFUND INC carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how DIAMOND BIOFUND INC's Asset Resilience Ratio has changed over time. See 6901 book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down DIAMOND BIOFUND INC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see DIAMOND BIOFUND INC market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$1.47 Billion | 15.65% |
| Total Liquid Assets | NT$1.47 Billion | 15.65% |
Asset Resilience Insights
- Good Liquidity Position: DIAMOND BIOFUND INC maintains a healthy 15.65% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
DIAMOND BIOFUND INC Industry Peers by Asset Resilience Ratio
Compare DIAMOND BIOFUND INC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sundaram Finance Holdings Limited
NSE:SUNDARMHLD |
Asset Management | 0.03% |
|
Cymbria Corporation
TO:CYB |
Asset Management | 4.18% |
|
Blue Star Capital plc
LSE:BLU |
Asset Management | 16.18% |
|
GIMV NV
BR:GIMB |
Asset Management | 8.42% |
|
FS KKR Capital Corp
NYSE:FSK |
Asset Management | 0.13% |
|
Oakley Capital Investments Limited
LSE:OCI |
Asset Management | 4.74% |
|
PM Capital Global Opportunities Fund Ltd
AU:PGF |
Asset Management | 97.40% |
|
Mirrabooka Investments Ltd
AU:MIR |
Asset Management | 1.36% |
Annual Asset Resilience Ratio for DIAMOND BIOFUND INC (2019–2024)
The table below shows the annual Asset Resilience Ratio data for DIAMOND BIOFUND INC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 46.88% | NT$5.00 Billion ≈ $157.65 Million |
NT$10.67 Billion ≈ $336.31 Million |
-10.97pp |
| 2023-12-31 | 57.85% | NT$7.54 Billion ≈ $237.68 Million |
NT$13.04 Billion ≈ $410.89 Million |
-35.09pp |
| 2022-12-31 | 92.94% | NT$10.40 Billion ≈ $327.79 Million |
NT$11.19 Billion ≈ $352.69 Million |
-1.85pp |
| 2021-12-31 | 94.79% | NT$10.07 Billion ≈ $317.24 Million |
NT$10.62 Billion ≈ $334.68 Million |
+9.31pp |
| 2020-12-31 | 85.48% | NT$7.93 Billion ≈ $249.93 Million |
NT$9.28 Billion ≈ $292.38 Million |
+58.10pp |
| 2019-12-31 | 27.38% | NT$843.00 Million ≈ $26.56 Million |
NT$3.08 Billion ≈ $97.02 Million |
-- |
About DIAMOND BIOFUND INC
Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.